GS-2121 is under clinical development by Gilead Sciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...

Which biotechs are most likely to be acquired near-term? We asked Seeking Alpha analysts Edmund Ingham and Terry Chrisomalis for their thoughts on the topic. Read more here.

Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

Viewers will get to say goodbye to the lovable characters of Netflix's Stranger Things, while saying hello to a new cast on ...

As preparations continue for the second Donald Trump presidency, immigration remains a contentious issue, with the H-1B visa ...

Ontario's Mason Turnbaugh became the 23rd three-time champ, Clear Fork's Blake Schlosser is a two-time champ and Ontario's ...

With the FDA approval of Gilead's seladelpar, there have now been two in a matter of weeks. The US agency has cleared seladelpar under the Livdelzi brand name as a second-line therapy for PBC in ...

Article analyzes Amgen's strong clinical progress and financials, recommending caution due to valuation and technical ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

Several Columbus-area high school sports events have been moved to avoid a conflict with the CFP semifinal between Ohio State and Texas.

Federal Reserve Bank of San Francisco President Mary Daly and Federal Reserve Board Governor Adriana Kugler speak as they attend the American Economics Association's annual conference, in San ...